Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides

NCT05322005 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniscus Tear
Meniscus Lesion

Interventions

PROCEDURE: partial meniscectomy
DEVICE: Condrotide® (polynucleotides gel: class III medical device)

Sponsor

Mastelli S.r.l